MARKET

ISRG

ISRG

Intuitive
NASDAQ

Real-time Quotes | Nasdaq Last Sale

729.82
+3.45
+0.48%
After Hours: 733.99 +4.17 +0.57% 15:58 11/27 EST
OPEN
735.37
PREV CLOSE
726.37
HIGH
735.57
LOW
726.00
VOLUME
265.39K
TURNOVER
--
52 WEEK HIGH
792.54
52 WEEK LOW
360.50
MARKET CAP
85.79B
P/E (TTM)
83.18
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Medtronic Sees a Recovery. ‘Disruptive Opportunities’ Are Next.
The pandemic interrupted sales for medical-device companies but the company said Tuesday that revenues recovered faster than expected in the October quarter.
Barrons.com · 5d ago
Medtronic Reclaims Breakout On 'Faster-Than-Expected' Covid Recovery
Investor's Business Daily · 5d ago
What We Learned About Intuitive Surgical's (NASDAQ:ISRG) CEO Pay
This article will reflect on the compensation paid to Gary Guthart who has served as CEO of Intuitive Surgical, Inc...
Simply Wall St. · 6d ago
Baird draws positive reads from early optimism in health system CFO survey
Baird's survey of health systems CFOs (80 of them, representing about $76B in annual revenue and about 84,000 licensed inpatient beds) points to a somewhat upbeat mood for 2021. Comps
Seekingalpha · 11/18 23:39
3 Best Buys from the Prospering Medical Instruments Industry
Zacks · 11/18 12:45
Abbott Labs, Intuitive Surgical Headline 5 Top Stocks Near Buy Points
Investor's Business Daily · 11/14 13:00
Why Intuitive Surgical (ISRG) Stock is a Compelling Investment Case
Polen Capital Management recently released its Q3 2020 Investor Letter, a copy of which you can download here. During the third quarter of 2020, the Polen Focus Growth Composite Portfolio returned 10.15% gross of fees, while the Russell 1000 Growth Index was up 13.22% and the S&P 500 Index was up 8.93%. You should check […]
Insider Monkey · 11/11 16:45
ROCE Insights For Intuitive Surgical
Looking at Q3, Intuitive Surgical (NASDAQ: ISRG) earned $270.40 million, a 235.48% increase from the preceding quarter. Intuitive Surgical also posted a total of $1.08 billion in sales, a 26.51% increase since Q2. In Q2, Intuitive Surgical brought in $852.10 million in sales but only earned $80.60 million.Why ROCE Is Significant Changes in earnings and sales indicate shifts in Intuitive Surgical's Return on Capital Employed, a measure of yearly pre-tax profit relative to capital employed by a business. Generally, a higher ROCE suggests successful growth of a company and is a sign of higher earnings per share in the future. In Q3, Intuitive Surgical posted an ROCE of 0.03%.It is important to keep in mind ROCE evaluates past performance and is not used as a predictive tool. It is a good measure of a company's recent performance, but several factors could affect earnings and sales in the near future.View more earnings on ISRGReturn on Capital Employed is an important measurement of efficiency and a useful tool when comparing companies that operate in the same industry. A relatively high ROCE indicates a company may be generating profits that can be reinvested into more capital, leading to higher returns and growing EPS for shareholders.In Intuitive Surgical's case, the positive ROCE ratio will be something investors pay attention to before making long-term financial decisions.Q3 Earnings Insight Intuitive Surgical reported Q3 earnings per share at $2.77/share, which beat analyst predictions of $2.07/share.See more from Benzinga * Click here for options trades from Benzinga * ROCE Insights For Cadence Design Systems * Analyzing RH's Unusual Options Activity(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga · 11/02 15:36
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ISRG. Analyze the recent business situations of Intuitive through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 19 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average ISRG stock price target is 730.31 with a high estimate of 815.00 and a low estimate of 365.00.
EPS
Institutional Holdings
Institutions: 1.48K
Institutional Holdings: 109.40M
% Owned: 93.06%
Shares Outstanding: 117.56M
TypeInstitutionsShares
Increased
399
3.40M
New
216
1.29M
Decreased
354
4.58M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+1.17%
Healthcare Equipment & Supplies
+1.44%
Key Executives
Chairman/Director
Craig Barratt
Chief Executive Officer/President/Director
Gary Guthart
Chief Financial Officer/Executive Vice President
Marshall Mohr
Executive Vice President
Myriam Curet
Executive Vice President
David Rosa
Senior Vice President/Chief Compliance Officer/General Counsel
Kara Andersen Reiter
Director
Joseph Beery
Independent Director
Amal Johnson
Independent Director
Don Kania
Independent Director
Amy Ladd
Independent Director
Keith Leonard
Independent Director
Alan Levy
Independent Director
Jami Nachtsheim
Independent Director
Mark Rubash
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About ISRG
Intuitive Surgical, Inc. (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company's da Vinci Surgical System consists of a surgeon's console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon's hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports. The da Vinci Surgical System provides its operating surgeons with control, range of motion, tissue manipulation capability and three-dimensional (3-D), high-definition (HD) vision. Intuitive has four generations of da Vinci Surgical System: the da Vinci Xi Surgical System, the da Vinci Si Surgical System, the da Vinci S Surgical System and the standard da Vinci Surgical System. The Company's instruments and accessories include EndoWrist Instruments and da Vinci Single-Site.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Intuitive Surgical, Inc. stock information, including NASDAQ:ISRG real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ISRG stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ISRG stock methods without spending real money on the virtual paper trading platform.